Professional Documents
Culture Documents
ABEL ABRAHAM
III MDS
TABLE OF CONTENTS
INTRODUCTION
DEFINITION
THEORIES OF PATHOGENESIS
CURRENT CONCEPT
CLASSIFICATION SYSTEMS
RISK FACTORS
CLINICAL FINDINGS
RADIOGRAPHIC FINDINGS
CONSERVATIVE MANAGEMENT
SURGICAL MANAGEMENT
CONCLUSION
INTRODUCTION
Malignancies of the maxillofacial region continue to plague our patients and often occupy
a large portion of our practices
Radiation therapy plays a valuable role in treatment of maxillofacial malignancies, but it
also has well-known and very real complications.
The most dreaded complication of radiation therapy to the jaws is the development of
osteoradionecrosis (ORN).
In 1922, Regaud published what was arguably the first report about osteoradionecrosis
(ORN) of the jaws after radiotherapy.
During the past 80 years, this condition has persisted as a consequence of radiotherapy for
head and neck cancer in an appreciable minority of patients
DEFINITION
Watson and Scarborough reported three crucial factors: ; exposure to radiotherapy above a
critical dose; local injury; and infection
Meyer suggested that injury provided the opening for invasion of oral microbiological
flora into the underlying irradiated bone
Marx proposed the hypoxic-hypocellular-hypovascular theory
Marx concluded, “ORN is not a primary infection of irradiated bone, but a complex
metabolic and homeostatic deficiency of tissue that is created by radiation-induced
cellular injury; micro-organisms play only a contaminating role in ORN; and trauma may
or may not be an initiating factor”
CONTEMPORARY UNDERSTANDING
Ulceration or necrosis of the mucosa with exposure of necrotic bone for longer
than 3 months,
Suppuration in the area
Neurological symptoms, such as pain, dysaesthesia or anaesthesia, as well as
fetor oris, dysgeusia and food impaction in the area
Exposure of rough and irregular bone can result in physical irritation of
adjacent tissues.
Progression of ORN may lead to pathological fractures,
intra-oral or extra-oral fistulae and local or systemic
infection.
Difficulties in mouth opening, mastication and speech
frequently arise
In patients treated with external beam radiation therapy
(EBRT), osseous alterations usually appear in the body of
the mandible (premolar and molar regions)
In those managed with brachytherapy, the lingual or buccal
surfaces are affected
The diagnosis of septic ORN appears to be easier.
Marked pain is the primary symptom.
Intra- or extra-oral draining fistulae, ulcerations of the mucous membrane
Exposed devitalised bone
Haemorrhage, cellulitis or pathological fractures.
A biopsy is mandatory for final diagnosis in order to exclude metastatic cancer
RADIOLOGICAL FINDINGS
Criteria for the extraction of teeth before radiation therapy include moderate to advanced
periodontal disease (pocket-depth of more than 5 mm);
extensive periapical lesions of the roots;
extensive tooth decay;
partially impacted or incompletely erupted teeth; and
residual root tips not fully covered by bone or showing radiolucency
Extractions should be performed atraumatically with careful tissue handling, with
alveolotomy and primary wound closure when possible.
An interval of 2 to 3 weeks’ healing time between tooth extraction and the onset of
radiation therapy is recommended
Role of Intensity-Modulated Radiation
Therapy
IMRT allows for higher doses of radiation to be targeted at the tumor and minimizes
collateral damage to the adjacent normal tissue.
Decreasing radiation exposure to the mandible has the potential to decrease ORN.
Ahmed et al showed that IMRT decreased the total maximum radiation dose to the
mandible and also decreased the volume of the mandible that was exposed to higher doses
of 50, 55, and 60 Gy
CONSERVATIVE MANAGEMENT
During HBOT, patients breathe 100% oxygen at increased pressures (2–3 atm).
This results in the increase of the tissue oxygen pressure
Leads to augmented endothelial cell and fibroblast proliferation.
In the long term it stimulates collagen synthesis, matrix deposition, angiogenesis, and
epithelialization which, in turn, promotes wound healing
Current protocol:
20 to 30 dives at 2.0 to 2.5 atmospheres for 90 to 120 minutes at each session, once a day
for 5 days. If a dental extraction or surgical procedure is performed, the patient takes an
additional 10 dives.
Complications include:
Eustachian tube dysfunction, middle ear barotrauma, seizure, and decompression
sickness. The main contraindications are optic neuritis and pulmonary disease
ULTRASOUND
Targets radiation-induced bone fibrosis and stimulates osteogenesis via the antioxidant
pathway.
Pentoxifylline is a methlyxanthine derivative that exerts an anti–TNF-a effect,
vasodilates, and inhibits inflammatory reactions.
Tocopherol (vitamin E) scavenges the ROS generated during oxidative stress.
These two drugs work synergistically as potent antifibrotic agents.
SURGICAL MANAGEMENT
ORN can be a devastating complication of radiation therapy after treatment of head and
neck cancer. While predisposing factors are clearly evident, there is an ongoing debate on
how best to define and classify this disease process. There is also controversy regarding
the best protocol for treatment, particularly the use of HBOT.
Radical resection and immediate well-vascularized tissue flap reconstruction seem to be
reliable and successful methods for a patient whose ORN does not respond to
conservative nonoperative treatment.
Preventing ORN occurrence is time consuming and demands teamwork, and the oral and
maxillofacial surgeon should minimize trauma to the jaws as much as possible, especially
for patients who need to receive postsurgical radiotherapy.
REFERENCES
Shaw, R. J., & Dhanda, J. (2011). Hyperbaric oxygen in the management of late radiation injury to the head and neck. Part I: treatment. British
Journal of Oral and Maxillofacial Surgery, 49(1), 2–8. doi:10.1016/j.bjoms.2009.10.036
Rommel N, Kesting MR, Rohleder NH, Wolff KD, Weitz J. Surgical management of severe osteoradionecrosis of the mandibular bone by
using double free flap reconstruction. J Craniomaxillofac Surg. 2018 Jan;46(1):148-154. doi: 10.1016/j.jcms.2017.09.025. Epub 2017 Nov 2.
PMID: 29174551.
Dai, T., Tian, Z., Wang, Z., Qiu, W., Zhang, Z., & He, Y. (2015). Surgical Management of Osteoradionecrosis of the Jaws. The Journal of
Craniofacial Surgery, 26(2), e175–e179. doi:10.1097/scs.0000000000001445
O’Dell, K., & Sinha, U. (2011). Osteoradionecrosis. Oral and Maxillofacial Surgery Clinics of North America, 23(3), 455–464.
doi:10.1016/j.coms.2011.04.011
Nadella KR, Kodali RM, Guttikonda LK, Jonnalagadda A. Osteoradionecrosis of the Jaws: Clinico-Therapeutic Management: A Literature
Review and Update. J Maxillofac Oral Surg. 2015;14(4):891-901. doi:10.1007/s12663-015-0762-9
Frederik K L Spijkervet, Michael T Brennan, Douglas E Peterson, Max J H Witjes, Arjan Vissink, Research Frontiers in Oral Toxicities of
Cancer Therapies: Osteoradionecrosis of the Jaws, JNCI Monographs, Volume 2019, Issue 53, August 2019, lgz006,
https://doi.org/10.1093/jncimonographs/lgz006
Chronopoulos A, Zarra T, Ehrenfeld M, Otto S. Osteoradionecrosis of the jaws: definition, epidemiology, staging and clinical and radiological
findings. A concise review. International dental journal. 2018 Feb 1;68(1):22-30.
Thorn JJ, Hansen HS, Specht L, Bastholt L. Osteoradionecrosis of the jaws: clinical characteristics and relation to the field of irradiation.
Journal of oral and maxillofacial surgery. 2000 Oct 1;58(10):1088-93.
Glick, M. (2015). Burket's oral medicine. PMPH USA.
Fonseca, R. J. (2017). Oral and Maxillofacial Surgery-E-Book: 3-Volume Set. Elsevier Health Sciences.
THANK YOU